Xvivo Perfusion AB (STU:3XV)
€ 38.3 0.6 (1.59%) Market Cap: 1.23 Bil Enterprise Value: 1.19 Bil PE Ratio: 132.53 PB Ratio: 6.92 GF Score: 83/100

Q2 2023 Xvivo Perfusion AB Earnings Call Transcript

Jul 13, 2023 / 12:00PM GMT
Release Date Price: €27.3 (+0.92%)
Operator

Welcome to XVIVO Q2 Report for 2023. (Operator Instructions) Now I will hand the conference over to CEO, Christoffer Rosenblad; and CFO, Kristoffer Nordstrom. Please go ahead.

Christoffer Rosenblad;publ;CEO
Xvivo Perfusion AB

()-

I want to welcome everyone to the earnings call for the second quarter of 2023 XVIVO. And with that, I turn to slide number 2 in the deck, just the pictures of the 2 presenters. It's me, Christoffer Rosenblad, CEO for XVIVO; and Kristoffer Nordstrom, CFO, for XVIVO on today's call. First, giving a presentation and then answering questions from all of you. And with that, we go over to slide 3, which is the Q2 finances at the glance. And to start with, we are pleased with the quarter with strong sales, strong growth. We continue to see strong growth on the organic side. We are helped by especially the strong U.S. dollar on the currency effect.

We continue to see strong EBITDA development. We have said that our financial goal 2027 is 30%, and we are progressing towards that goal. We could -- I said

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot